The absence of dystrophin, as seen in patients with Duchenne muscular dystrophy (DMD) and its animal equivalent the mdx mouse, leads to a significant reduction in skeletal muscle nNOS expression and in skeletal muscle blood flow (Brenman et al. 1995). Here, DMD is linked to Duchenne muscular dystrophy.